Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease

Background: Myeloperoxidase (MPO) and advanced oxidation protein products, or AOPP (a type of MPO-derived chlorinated adducts), have been implicated in Parkinson´s disease (PD). Human MPO also show sex-based differences in PD. The objective was to study the relationship of MPO and AOPP in the cerebr...

Full description

Bibliographic Details

Published in:	Antioxidants
Main Authors:	Emilio Fernández-Espejo, Fernando Rodríguez de Fonseca, Ana Luisa Gavito, Antonio Córdoba-Fernández, José Chacón, Ángel Martín de Pablos
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Subjects:	myeloperoxidase advanced oxidation protein products cerebrospinal fluid Parkinson’s disease duration
Online Access:	https://www.mdpi.com/2076-3921/11/6/1088